Clinical spectrum and severity of psoriasis

Current Problems in Dermatology

Volumn 38, Issue , 2009, Pages 1-20

  Meier, Matthew ^a   Sheth, Pranav B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; LITHIUM; POTASSIUM HYDROXIDE;

ACRODERMATITIS CONTINUA; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; BACTERIUM CULTURE; BLOOD CELL COUNT; BODY SURFACE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CIGARETTE SMOKING; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERYTHRODERMIC PSORIASIS; GEOGRAPHIC TONGUE; HEART INFARCTION; HEPATITIS B; HEPATITIS C; HEREDITY; HUMAN; HYPERLIPIDEMIA; INFECTION; LICHENOID ERUPTION; LYMPHOMA; MENTAL STRESS; OBESITY; PATHOGENESIS; PATIENT CARE; PATIENT REFERRAL; PITYRIASIS ROSEA; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS GUTTATA; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; QUALITY OF LIFE; RACE DIFFERENCE; RATING SCALE; REVIEW; SCREENING TEST; SEBORRHEIC DERMATITIS; SKIN BIOPSY; SKIN EXAMINATION; SKIN INJURY; SKIN SURGERY; SMALL PLAQUE PSORIASIS; SYPHILIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; VIRUS CULTURE; VIRUS DETECTION; HOSPITALIZATION; PROGNOSIS; RISK FACTOR;

HUMANS; PROGNOSIS; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 70350515930     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000232301     Document Type: Review

References (48)

1. Gudjonsson JE, Elder JT: Psoriasis: epidemiology. Clin Dermatol 2007;25:535-546.
2. Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thoma J, Kist J, Rolstad T, Margolis DJ: The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005;52:23-26.
3. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J: A population genetic study of psoriasis. Acta Derm Venereol Suppl (Stockh) 1994;186:7-8. (Pubitemid 24208137)
4. Elder JT: PSORS1: linking genetics and immunology. J Invest Dermatol 2006;126:1205-1206.
5. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NVC, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT: Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genetics 2006;78:827-851.
6. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ: Fitzpatrick's Dermatology in General Medicine, ed 7. New York, McGraw Hill, 2008, vol 1, pp 170-179.
7. Lowes MA, Bowcock AM, Krueger JG: Pathogenesis and therapy of psoriasis. Nature 2007;445:866-873.
8. Farber EM, Nall ML: The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18.
9. Bernhard JD: Auspitz sign is not sensitive or specific for psoriasis. J Am Acad Dermatol 1990;22(part 1):1079-1081.
10. Penneys NS, Ziboh V, Simon P: Pathogenesis of Woronoff ring in psoriasis. Arch Dermatol 1976; 112:955-957.
11. Wang G, Li C, Gao T, Liu Y: Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol 2005;15:176-178.
12. Griffiths CEM, Christophers E, Barker JNWN, Chalmers RJG, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L: A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007;156:258-262.
13. Telfer NR, Chalmers RJG, Whale K, Colman G: The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992;128:39-42.
14. Owen CM, Chalmers R, O'Sullivan T, Griffiths CEM: Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2000;2:CD001976. DOI: 10.1002/14651858. CD001976.
15. Boyd AS, Menter A: Erythrodermic psoriasis: precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989;21(part 1):985-991.
16. Rothe MJ, Bialy TL, Grant-Kels JM: Erythroderma. Dermatol Clin 2000;18:405-415.
17. Zelickson BD, Muller SA: Generalized pustular psoriasis. Arch Dermatol 1991;127:1339-1345.
18. Abou-Samra T, Constantin JM, Amarger S, Mansard S, Souteyrand P, Bazin JE, D'Incan M: Generalized pustular psoriasis complicated by acute respiratory distress syndrome. Br J Dermatol 2004; 150:353356.
19. Baker H, Ryan TJ: Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol 1968;80:771-793.
20. Rook A, Champion JL, Burton JL, Wilkinson DS, Burns DA, Ebling FJG, Breathnach SM: Rook/ Wilkinson/Ebling Textbook of Dermatology, ed 6. London, Blackwell Science, 1998, vol 2, pp 16331636.
21. Liao PB, Rubinson R, Howard R, Sanchez G, Frieden IJ: Annular pustular psoriasis -most common form of pustular psoriasis in children: report of 3 cases and review of the literature. Pediatr Dermatol 2002; 19:19-25.
22. Rosen RM: Annular pustular psoriasis induced by UV radiation from tanning salon use. J Am Acad Dermatol 1991;25(part 1):336-337.
23. Chaidemenos G, Lefaki I, Tsakiri A, Mourellou O: Impetigo herpetiformis: menstrual exacerbations for 7 years postpartum. Eur Acad Dermatol Venereol 2005;19:466-469.
24. Breier-Maly J, Ortel B, Breier F, Schmidt JB, Honigsmann H: Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 1999;198:61-64. (Pubitemid 29086337)
25. Oumeish OY, Farraj SE, Bataineh AS: Some aspects of impetigo herpetiformis. 1982;118:103-105.
26. Lotem ML, Katzenelson V, Rotem A, Hod M, Sandbank M: Impetigo herpetiformis: a variant of pustular psoriasis or a separate entity? J Am Acad Dermatol 1989;20(part 2):338-341.
27. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY: Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007;57: 1-27.
28. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM: Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009;61:233-239.
29. Zhu JF, Kaminski MJ, Pulitzer DR, Hu J, Thomas HF: Psoriasis: pathophysiology and oral manifestations. Oral Dis 1996;2:135-144.
30. Hernandez-Perez F, Jaimes-Aveldanez A, Urquizo-Ruvalcaba Mde L, Diaz-Barcelot M, Irigoyen-Camacho ME, Vega-Memije ME, Mosqueda-Taylor A: Prevalence of oral lesions in patients with psoriasis. Med Oral Patol Oral Cir Bucal 2008;13: E703-E708.
31. Miloglu O, Goregen M, Akgul HM, Acemoglu H: The prevalence and risk factors associated with benign migratory glossitis lesions in 7,619 Turkish dental outpatients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:e29-e33.
32. Morris AM, Rogers M, Fischer G, Williams K: Childhood psoriasis: a clinical review of 1,262 cases. Pediatr Dermatol 2001;18:188-198.
33. Seyhan M, Coskun BK, Saglam H, Ozcan H, Karincaoglu Y: Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int 2006;48:525-530.
34. Malhotra SK, Mehta V: Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol 2008; 74:594-599.
35. Dika E, Bardazzi F, Balestri R, Maibach HI: Environmental factors and psoriasis. Curr Probl Dermatol 2007;35:118-135.
36. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A: Guidelines of care for the management of psoriasis and psoriatic arthritis. 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008;58: 851-864. (Pubitemid 351509657)
37. Gelfand JM, Neimann AL, Shin DB: Risk of myo-cardial infarction in patients with psoriasis. JAMA 2006;296:1735-1741.
38. Kaye JA, Li L, Jick SS: Incidence of risk factors for myocardial infarction and other vascular disease in patient with psoriasis. Br J Dermatol 2008;159:895-902.
39. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM: Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829-835. (Pubitemid 44556851)
40. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB: The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006;126: 2194-2201.
41. Smedby KE, Vajdic CM, Falster M, et al: Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111:40294038.
42. Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O: Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 2008;58:657-666.
43. Kurd SK, Gelfand JM: The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009;60:218-224.
44. Berth-Jones J, Grotzinger K, Rainville C, Pham B, Huang J, Daly S, Herdman M, Firth P, Hotchkiss K: A study examining inter-and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 2006;155:707-713.
45. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CEM, Assche ADV: Development of the PSORI, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003;149:323-331.
46. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, Beutner KR, Bhushan R: Guidelines of care for the management of psoriasis and psoriatic arthritis. 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008;58:826-850. (Pubitemid 351509656)
47. Gardune J, Bhosle MJ, Balkrishnan R, Feldman SR: Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review. J Dermatol Treat 2007;18:223-242.
48. Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ: National psoriasis foundation clinical consensus on disease severity. Arch Dermatol 2007;143:239-242.